economic activity done by a businessperson
Therapy for relapsed and refractory multiple myeloma: Janssen Pharmaceutical Companies of Johnson & Johnson announced that CARVYKTI®▼ (Ciltacabtagene autoleucel; ...
medical-tribune.de/medizin-und-forschung/artikel/erste-bcma-gerichtete-therapie
Paul Mescal’s mum has said she is “blessed beyond words” as she shared some positive news on her battle with cancer.
Dearbhla Mescal was diagnosed with a form ... Show more
A Visual Guide to Multiple Myeloma: Learn the basics of multiple myeloma: causes, symptoms and treatment.
webmd.com/cancer/multiple-myeloma/ss/slideshow-multiple-myeloma
$JNJ | Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future
The Multiple myeloma franchise performed well in the ... Show more
Johnson & Johnson’s bone cancer drug gets USFDA nod: Multiple myeloma is an incurable blood cancer that affects a type of white blood cell called plasma cells ...
financialexpress.com/healthcare/pharma-healthcare/johnson-johnsons-bone-cancer-drug-gets-usfda-nod/3450386/
Time to Stop Routine Maintenance Therapy in Myeloma?: Physicians may need to rethink maintenance with lenalidomide (Revlimid and generics) for multiple myeloma.
medscape.com/s/viewarticle/time-stop-routine-maintenance-therapy-myeloma-2023a1000tw8
Regeneron Pharmaceuticals Inc. (REGN) American Society of Hematology 2023 Investor Conference - (Transcript)
seekingalpha.com/article/4657940-regeneron-pharmaceuticals-inc-regn-american-society-of-hematology-2023-investor-conference
Multiple myeloma: “Today you can get 80-90% into a good remission”: Myeloma patients have significantly more treatment options today than they did ten years ago ...
medical-tribune.de/medizin-und-forschung/artikel/prof-dr-heinz-ludwig-im-podcast-o-ton-onkologie-zur-behandlung-des-multiplen-myeloms
Louise Glück, Nobel prize-winning poet, dies at 80: Pulitzer prize winner and former US poet laureate was known for her sharp, austere lyrical work
theguardian.com/books/2023/oct/13/louise-gluck-prize-winning-american-poet-dead
Quick Glance: US Nobel-winning poet Louise Gluck passes away at 80
- Louise Gluck, an American poet and winner of the 2020 Nobel Prize for Literature, poses outside her home in Cambridge.
- Her poetry was renowned for its candor in exploring family and childhood with a distinctive voice and austere beauty, as stated by the Swedish Academy responsible for selecting the literature prize winner.
- Drawing comparisons with 19th-century US poet Emily Dickinson, the Academy highlighted Gluck's severity and unwillingness to accept simplistic beliefs.
- Gluck received the Pulitzer Prize in 1993 for her poetry collection 'The Wild Iris,' with the title poem delving into suffering and evoking imagery of the natural world.
Belantamab-Mafodotin: Approval is questionable, G-BA had to certify additional benefit
aerzteblatt.de/nachrichten/146437/Belantamab-Mafodotin-Zulassung-steht-infrage-G-BA-musste-Zusatznutzen-bescheinigen
Multiple myeloma: recurrence after immunotherapy due to antigen loss: Calgary - Despite the therapeutic successes that can be achieved in multiple myeloma with ...
aerzteblatt.de/nachrichten/146121/Multiples-Myelom-Rezidiv-nach-Immuntherapie-durch-Antigenverlust
Tiger Work by Ben Okri audiobook review – dispatches on a post-apocalyptic world: Ashley Zhangazha narrates a collection of essays, poems and short stories that ...
theguardian.com/books/2023/sep/22/tiger-work-by-ben-okri-audiobook-review-dispatches-on-a-post-apocalyptic-world
Dara-CVRd Induction and Prolonged Post-ASCT Dara-VRd Consolidation Beneficial for Ultra-High-Risk Myeloma
medical-tribune.de/medizin-und-forschung/artikel/dara-cvrd-induktion-und-verlaengerte-post-asct-dara-vrd-konsolidierung-fuer-das-ultrahochrisiko-myelom-von-vorteil
US FDA approves Pfizer's blood cancer therapy: The U.S. Food and Drug Administration on Monday granted accelerated approval to Pfizer's (PFE ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-blood-cancer-therapy-2023-08-14/
FDA clears drug to help harvest stem cells to treat multiple myeloma patients: The injectable will be sold by an Israeli biotech BioLineRx, which has its US ...
bostonglobe.com/2023/09/11/business/fda-clears-drug-help-harvest-stem-cells-treat-multiple-myeloma-patients/
Immune system plays vital role in longer multiple myeloma remission, new study shows
medicalxpress.com/news/2023-09-immune-plays-vital-role-longer.html
Cancer: Beau the cat nurses owner after myeloma diagnosis: David's 11-year-old rescue cat has barely left his side since his incurable blood cancer diagnosis.
bbc.com/news/uk-wales-66164088
Audrey Greene, a retired sales agent from Long Neck, Del., celebrated her 80th birthday in March. Diagnosed in 2010 at age 68 with multiple myeloma ... Show more
wapo.st/3qTIJP9
wapo.st/3qTIJP9
VA reviews possible link between toxic exposures, certain cancers in service members - UPI.com
upi.com/Top_News/US/2023/07/25/veterans-affairs-cancers-link-toxic-exposures/5961690340215/
The 'Perfect Storm' That Led To A Patient Death And Arcellx's Dive: The FDA placed a study of Arcellx's multiple myeloma drug on hold after a patient died ...
investors.com/news/technology/aclx-stock-plunges-after-perfect-storm-leads-to-patient-death-in-cancer-drug-study/
Testing hundreds of therapeutics outside the body to predict their effectiveness against multiple myeloma
medicalxpress.com/news/2023-04-hundreds-therapeutics-body-effectiveness-multiple.html
Legend Biotech Soars After Cancer Drug Trial Results Revealed Early: Legend Biotech Corp. shares jumped as much as 21%, the most since June 2020 ...
bloomberg.com/news/articles/2023-04-19/legend-legn-soars-after-key-cancer-drug-trial-results-released-early
Research success in Ottakring: Many cancer patients are spared chemo - Ottakring: Researchers from the Ottakring Clinic give the all-clear for patients with the ...
meinbezirk.at/ottakring/c-gesundheit/vielen-krebspatienten-bleibt-chemo-erspart_a5946661
Claims against Dr. Reddy’s dismissed over Revlimid in United States; Share price rises
financialexpress.com/healthcare/news-healthcare/claims-against-dr-reddys-dismissed-over-revlimid-in-united-states-share-price-rises/2930880/
Novel PET agent effectively detects multiple cancers, identifies patients for targeted therapies
medicalxpress.com/news/2022-11-pet-agent-effectively-multiple-cancers.html
GSK's blood cancer drug fails main goal of trial, shares fall: GSK's (GSK.L) blood cancer drug Blenrep failed the main goal of a late-stage study designed to ...
reuters.com/business/healthcare-pharmaceuticals/gsks-blood-cancer-drug-fails-main-goal-superiority-trial-2022-11-07/
CAR T-cell therapy proves effective in first trial in patients with resistant multiple myeloma
medicalxpress.com/news/2022-09-car-t-cell-therapy-effective-trial.html
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics